AGENDA:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing te
Join our CEO Kevin Hrusovsky, Dr. Jessica Gill (NIH) and Dr. Henrik Zetterberg (University of Gothenburg) as they discuss how Simoa Technology uses ultrasensitive biomarker assays to enable precision health with case studies in neurodegeneration and neurotrauma.
AGENDA:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing te
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
